Timing and trajectory of BCR::ABL1-driven chronic myeloid leukaemia.

Saved in:
Bibliographic Details
Title: Timing and trajectory of BCR::ABL1-driven chronic myeloid leukaemia.
Authors: Kamizela AE; Wellcome Sanger Institute, Hinxton, UK.; Cambridge Stem Cell Institute and Department of Haematology, University of Cambridge, Cambridge, UK.; Cambridge University Hospitals NHS Trust, Cambridge, UK., Leongamornlert D; Wellcome Sanger Institute, Hinxton, UK., Williams N; Wellcome Sanger Institute, Hinxton, UK., Wang X; Wellcome Sanger Institute, Hinxton, UK.; Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Nyamondo K; Wellcome Sanger Institute, Hinxton, UK.; Cambridge Stem Cell Institute and Department of Haematology, University of Cambridge, Cambridge, UK.; Cambridge University Hospitals NHS Trust, Cambridge, UK., Dawson K; Wellcome Sanger Institute, Hinxton, UK., Spencer Chapman M; Wellcome Sanger Institute, Hinxton, UK.; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Guo J; Wellcome Sanger Institute, Hinxton, UK., Lee J; Wellcome Sanger Institute, Hinxton, UK.; Cambridge Stem Cell Institute and Department of Haematology, University of Cambridge, Cambridge, UK., Mane K; Wellcome Sanger Institute, Hinxton, UK.; Cambridge Stem Cell Institute and Department of Haematology, University of Cambridge, Cambridge, UK., Milne K; Cambridge University Hospitals NHS Trust, Cambridge, UK., Green AR; Cambridge Stem Cell Institute and Department of Haematology, University of Cambridge, Cambridge, UK.; Cambridge University Hospitals NHS Trust, Cambridge, UK., Chevassut T; Department of Clinical and Experimental Medicine, Brighton and Sussex Medical School, Brighton, UK., Campbell PJ; Wellcome Sanger Institute, Hinxton, UK.; Cambridge Stem Cell Institute and Department of Haematology, University of Cambridge, Cambridge, UK., Ellinor PT; Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA, USA., Huntly BJP; Cambridge Stem Cell Institute and Department of Haematology, University of Cambridge, Cambridge, UK.; Cambridge University Hospitals NHS Trust, Cambridge, UK., Baxter EJ; Cambridge University Hospitals NHS Trust, Cambridge, UK., Nangalia J; Wellcome Sanger Institute, Hinxton, UK. jn5@sanger.ac.uk.; Cambridge Stem Cell Institute and Department of Haematology, University of Cambridge, Cambridge, UK. jn5@sanger.ac.uk.; Cambridge University Hospitals NHS Trust, Cambridge, UK. jn5@sanger.ac.uk.
Source: Nature [Nature] 2025 Apr; Vol. 640 (8060), pp. 982-990. Date of Electronic Publication: 2025 Apr 09.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-4687
DOI:10.1038/s41586-025-08817-2